Our board of directors is responsible for corporate governance and is ultimately accountable for the group's activities, strategy, risk management and financial performance. Our Chief Executive Officer is responsible for the management of the business and is assisted by the GSK leadership team (GLT)...
Meet our leaders Board of directors and leadership team Committees GovernancePolicy positions We have policies in place across GSK to ensure we meet the high standards we set ourselves as a company, and those that are expected of us externally....
Our Board has established a corporate governance framework with clearly defined responsibilities and accountabilities.
17 GlaxoSmithKline Pharmaceuticals Limited | Annual Report 2021-22 Board of Directors (As on 15.06.2022) Chairperson Ms. R. S. Karnad Managing Director S. Venkatesh Directors M. Anand (w.e.f. 16.05.2022) P. V. Bhide J. Chandy (w.e.f. 01.04.2022) M. Dawson (upto 30.06.2022) N. ...
Emma will join the GSK Board of Directors from 1 January 2017. ? Emma has been the Chief Executive Officer (CEO) of GSK Consumer Healthcare, one of the world’s largest consumer health companies, since March 2015. ? She joined GSK in 2010 from L’Oreal where, in her 17-year ...
2.https://www.gsk-china.com/zh-cn/media/press-releases/gsk-and-zhifei/ 3.https://www.gsk.com/en-gb/media/press-releases/gsk-and-zhifei-announce-exclusive-strategic-vaccine-partnership-in-china/ 4.https://www.gsk.com/en-gb/company/board-of-directors-and-leadership-team/luke-miels/...
GSK Pakistan Annual Report 2024 Quarterly results You might also like Our products We research and develop a broad range of innovative products Pharmaceuticals and Vaccines Career opportunities at GSK Discover the work we do and the opportunities that exist, from research and development through to ma...
s Board of Directors has unanimously recommended that Sierra’s stockholders vote in favour of the approval of the merger. Additionally, stockholders of Sierra Oncology holding approximately 28 per cent of Sierra’s outstanding shares, have agreed to vote their shares i...
However, all of those studies would be published in a peer reviewed journal". A member of the board of directors at Roche, William Burns, added that both companies "are the first two out of the gate actually saying we will have a new policy going forward with greater disclosure than we'...
s Board of Directors has unanimously recommended that Sierra’s stockholders vote in favour of the approval of the merger. Additionally, stockholders of Sierra Oncology holding approximately 28 per cent of Sierra’s outstanding shares, have agreed to vote their shares in fav...